We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
When FDA Commissioner Scott Gottlieb got his job, critics called him a shill and industry types figured they'd gained a friend in the most important drug regulatory agency in the world. It didn't turn out quite that way.